Group A - Menstrual Disorders and Gynaecological Cancer Flashcards
Define dysfunctional uterine bleeding (DUB)
Heavy menstrual bleeding, with:
- No recognisable pelvic pathology
- No pregnancy
- No bleeding disorders
I.e. it is a diagnosis of exclusion
List some causes of abnormal/heavy menstrual bleeding
PALM COEIN
Polyps
Adenomyosis
Leiomyomas (fibroids)
Malignancy
Coagulation disorders
Ovulatory pathology
Endometriosis
Iatrogenic
Not yet classified
Outline the factors that determine whether a woman with HMB is low risk or high risk and what investigations they need based on their risk
Low risk:
< 45
No intermenstrual bleeding
No risk factors for endometrial cancer
Investigations: FBC only (anaemia) - then begin treatment for HMB
High risk:
> 45
Intermenstrual bleeding
Risk factors for endometrial cancer
Investigations: FBC (anaemia), ultrasound and hysteroscopy + biopsy
Then begin treatment for HMB
Outline the medical and surgical management of HMB
Medical:
- Tranexamic acid (symptomatic)
- Mefenamic acid (symptomatic)
- GnRH analogues or Ulipristal acetate (fibroids)
- Progesterone hormone products, Mirena coil 1st line
- COCP
Surgical:
- Hysteroscopic removal (polyps)
- Myomectomy (fibroids)
Risk of reducing children in future…
- Uterine artery embolisation
- Endometrial ablation
- Hysterectomy
Outline how to manage HMB in the short term / emergency
- Tranexamic acid
- Norethisterone (progesteron product)
- GnRH analongues
Outline how tranexamic acid works in HMB
Inhibits plasminogen activation
Reduces fibrolysis (encourages clotting)
= Reduces menstrual loss
Outline how mefenamic acid works in HMB
NSAID - reduces production of prostaglandins
= Analgesia, anti inflammatory and reduces menstrual loss (although less effectively than tranexamic acid)
List the following cancers in most common to least common
- Endometrial
- Cervical
- Vulval
- Ovarian
- Endometrial
- Ovarian
- Cervical
- Vulval
For the following cancers, state the peak age of incidence:
- Endometrial
- Ovarian
- Cervical
Endometrial: 65-75 (declines after 80)
Ovarian: 70-75 years (mostly between 50-80)
Cervical: bimodal at 30s and 80s
Outline risk factors for endometrial cancer
Also list some protective factors
Risk factors:
Anything that causes endometrial hyperplasia!
- Obesity
- BRCA1/2
- Lifetime exposure to oestrogen e.g. nulliparity, early menarche, late menopause
- Unopposed oestrogen = PCOS or Tamoxifen
- Poorly controlled diabetes
- Untreated endometrial polyps
Protective factors:
- SMOKING
- Combined HRT
- COCP
- Physical activity
Briefly explain endometrial hyperplasia and its management
- Precancerous condition, involving thickening of endometrium
- 2 types:
1. Hyperplasia without atypia
2. Atypical hyperplasia
Most cases will return to normal over time, however <5% can become endometrial cancer
- Risk factors are similar to those for endometrial cancer
Management:
Depends on type of hyperplasia
1. Hyperplasia without atypia = progesterone (POP or Mirena coil)
2. Atypical hyperplasia = hysterectomy +/- bilateral salpingo oophorectomy
List red flag symptoms for endometrial cancer
- Postmenopausal bleeding
- Abnormal vaginal discharge
If premenopausal:
- Heavy vaginal bleeding
- Abnormal bleeding e.g. IMB, PCB
Outline the main cell type of endometrial carcinoma
80% = adenocarcinoma
Outline referral criteria for post-menopausal bleeding and diagnostic tests indicated
Automatic 2 week wait urgent gynae cancer referral for endometrial cancer
- Transvaginal ultrasound (thickness > 4mm)
- If >4mm: endometrial (Pipelle) biopsy
- If high risk/suspicious: hysteroscopy + biopsy
Other than post-menopausal bleeding, suggest other presenting symptoms that prompt a referral for investigation of endometrial cancer in women over 55
In women over 55:
- Unexplained vaginal discharge
- Visible haematuria PLUS anaemia / raised platelets / raised glucose
Outline management options for endometrial cancer in terms of surgical and non-surgical options
Surgical:
- Total hysterectomy +/- bilateral salpingo oophorectomy
Non-surgical:
- Progestagens e.g. Mirena coil
- Primary radiotherapy
PLUS adjuvant therapies:
- External beam
- Brachytherapy
Depends on stage:
Stage 1 (localised) = total hysterectomy +/- bilateral salpingo oophorectomy with peritoneal wash out
Stage 2 = Radical hysterectomy and lymphadenectomy +/- adjuvant therapy
Stage 3 = Maximal debulking surgery + chemotherapy + radiotherapy
Stage 4 = Maximal debulking surgery / palliative approach
Outline the most common cell line types for ovarian cancer
Epithelial:
- Serous
- Mucinoid
Germ cell:
- Teratoma
Stomal / sex cord: rare!
Outline risk factors for ovarian cancer
Also list some protective factors
Risk factors:
- Obesity
- Lifetime exposure to oestrogen e.g. nulliparity, early menarche, late menopause
- BRCA1/2 or family history
- Unexposed oestrogen = PCOS or Tamoxifen
- Endometriosis
Protective factors:
- COCP
- Pregnancy / breastfeeding
- Oopherectomy (+/- hysterectomy)
Outline some red flag symptoms for a patient with ovarian cancer
- Persistent abdominal bloating
- Pain or dyspareunia
- Anorexia
- Nausea and vomiting
- Weight loss
- Vaginal bleeding
- Increased urinary frequency
- Bowel changes
Outline some diagnostic tests to consider for suspected ovarian cancer
Bloods:
- Ca125 tumour marker
- FBC / U&Es, LFTs (routine bloods)
Imaging:
- Ultrasound
- CT to assess for further disease
- Chest x-ray
Outline the possible management options for ovarian cancer: epithelial and non-epithelial
Epithelial:
- Surgery
- Chemotherapy (Platinum and Taxane)
Non-epithelial:
- Chemotherapy only (very chemo-sensitive)
Outline risk factors for cervical cancer
Also list some protective factors
Risk factors:
- Non-compliance with cervical screening
- Known diagnosis of CIN (premalignant changes)
- HPV positive
- Related to HPV exposure: early first sexual experience, multiple sexual partners, lack of barrier contraception
- Immunosuppression
- Smoking
- COCP long term
Protective factors:
- HPV vaccine!
- Compliance with cervical screening
Outline briefly how HPV increases the risk of cervical cancer
- HPV produce E6 and E7 proteins
- These proteins inhibit the tumour suppressor genes in keratinocytes
Briefly explain cervical intraepithelial neoplasia (CIN) and at which area of the cervix CIN occurs
CIN is a grading system for level of dysplasia / premalignant changes in the cells of the cervix
- Can be diagnosed during colposcopy
- Level of CIN grade, suggests the level of premalignant changes and the likely of progression to cervical cancer
Area of the cervix:
- Transformation zone
List some red flag symptoms for cervical cancer
- Post-coital bleeding
- Intermenstrual bleeding
- Post menopausal bleeding
- Dyspareunia
- Blood stained vaginal discharge
Outline the FIGO staging of cervical cancer
Stage 1: confined to cervix
Stage 2: beyond cervix, but not on side pelvic wall or lower 1/3 vagina
Stage 3: spreads beyond cervix, on sides of pelvic wall or lower 1/3 vagina
Stage 4: invades adjacent organs
Outline the management for cervical cancer in the following conditions:
- CIN and early stage 1a (very early disease)
- 1b to 2a (localised)
- 2b to 4a (greater spread)
CIN and early stage 1a:
- LLETZ procedure
- Cone biopsy
1b to 2a (localised):
- Radical hysterectomy and removal local lymph nodes with chemo and radio
2b to 4a (greater spread):
- Chemotherapy
- Radiotherapy